Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-23

Clinical Trial Update: Rectal Dexmedetomidine Niosomes for Postoperative Analgesia in Pediatric Cancer Patients. [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for rectal dexmedetomidine niosomes assessing postoperative analgesia in pediatric cancer patients, currently in Phase 2/Phase 3 with st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rectal dexmedetomidine niosomes (dexmedetomidine)

Snippet

Sponsor: Assiut University | Conditions: Postoperative Pain | Phase 2, Phase 3 | Status: UNKNOWN